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STUDY PROTOCOL: 
THE EFFECT OF THE FIFA 11 PREVENTION 
PROGRAMMES ON THE OVERALL INJURY RATE 
IN FOOTBALL: A SYSTEMATIC REVIEW 
AND META-ANALYSIS  
 
 
Version changes 
From 1.0 Æ 1.1 marked with yellow, and includes: 
1. Changed number and date of the protocol version 
2. Included extra affiliation for Ernest Esteve 
3. Included extra affiliation for Michael Skovdal Rathleff 
4. Changed literature search dates 
5. Changed search strategy: warm up changed to warmup, as this is a more correct term. The search 
will not be updated after the analyses have been conducted, unless submission is severely delayed 
and the search can be considered outdated. 
6. Made changes to “Implementation of statistical analyses plan” section. As Michael Skovdal Rathleff 
has appeared on a letter to the editor in December, 2015, together with the rest of the author 
group of the present study, concerning studies on FIFA prevention programmes, we can no longer 
consider him blinded to this kind of information during the statistical analyses. As Michael Rathleff 
cannot influence the data provided by each study, we do not consider this to bias the statistical 
analyses in any way, and Michael Rathleff will still be doing all the statistical analyses.
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INTRODUCTION 
More than 265 million people around the world are estimated by Fédération Internationale de 
Football Association (FIFA) to participate regularly in football (soccer).1 Football has been 
recognised, together with running, as one of the most promising sport and leisure time activities 
to induce important health benefits.2 Football improves cardiovascular and metabolic health,2  and 
prevent risk factors for lifestyle diseases such as diabetes and hypertension.3 However, football 
includes an inherent risk of injury,4;5 which is why  injury prevention in football is crucial.6 Not only 
does it keep people playing, it also makes it possible to achieve the health benefits associated with 
the game. Each year 5.8 million people are treated at the hospital due to injuries associated with 
sports.7 Team ball sports account for 43% of all hospital-related sports treatment – and football 
accounts for the majority (67%) of these.7 The FIFA Medical Assessment and Research Centre (F-
MARC) recently decided to combine the direct health effects of playing the game with education 
and prevention, and has in connection with this created a comprehensive football-based health 
education programme called “11 for Health”.3;8  
 
FIFA has since 2004 been focusing on strategies for injury prevention by introducing the FIFA 11 
programme for injury prevention in football.9 F-MARC developed and tested the FIFA 11 
programme which has been applied in different areas of organised football to prevent and reduce 
injury among the many people participating in the sport at the amateur and grassroots level.6;9 
The programme includes specific strengthening, balancing and plyometric exercises, and is to be 
included during a structured warm-up session. It has been tested in different football cohorts with 
varying results.10 Two variations of the 11 programme have been developed and provided by FIFA, 
the FIFA 11 and the FIFA 11+.10 The FIFA 11+ is a revised version of the original FIFA 11 
programme.10-12 The FIFA 11+ includes similar key exercises as the FIFA 11 with minor additions, 
including a more dynamic warm-up and a more specific progression model for the included 
exercises, to allow for more variation and physical improvement.10-12 In this way, it aims for 
optimising improvements in strength, balance and plyometric ability, which may lead to injury 
reduction.10-12  
 
The reason for revising the 11 programme in 2006 was that the 11 programme was found 
unsuccessful in reducing injury based upon a single study.11;12 However, a finding of no differences 
in injury estimates from a single study cannot be considered proof of no effect. Simply, this could 
be due to insufficient power to detect reductions in injury rates of less than the 40%, which the 
first FIFA 11 trial was powered to detect.12 This means that relevant effects on injury reduction of 
less than 40% could potentially exist from the FIFA 11 programmes, but that an increased number 
of participants may be needed to detect such a difference. Pooling data from individual studies 
into a meta-analysis offer an opportunity to increase statistical power and test whether the FIFA 
programmes are associated with injury reduction, as originally hypothesized in the initial studies 
where FIFA was involved.10-12  
 
With an increase over recent years in the number of studies investigating the preventive effect of 
the FIFA 11 programmes,10 with the first study being initiated in 2004,9 it now seems timely to 
address the important question: Is there a preventive (injury reducing) effect of the FIFA 11 
programme on the overall injury rate in football players? Now, more than ever, this questions is of 
particular relevance, as it was recently proclaimed by Bizzini and Dvorak (2015) from the F-MARC 
group, in a narrative review in British Journal of Sports medicine,6 that by “prioritising injury 
prevention through the 11+ programme leading to protecting a football player” overall health will 
be further pursued by FIFA and F-MARC through worldwide promotion of the FIFA 11+ prevention 
programme among the member associations. This with the specific strategic goal: “to prevent 
football injuries and to promote football as a health-enhancing leisure activity, improving social 
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behaviour”.6 While such a strategy is clearly relevant and appealing, it also relies on the premise 
that the FIFA 11 programmes are actually capable of reducing the overall number football injuries, 
which from individual studies does not seem to be a consistent finding in the existing literature.10   
 
Thus, the primary objective of the present study is, based on available (published) studies, to 
investigate the effect, positive as well as negative, of the FIFA 11 prevention programmes 
compared with control interventions (no or sham interventions), on the overall injury rate in 
football.  
We hypothesize that the FIFA 11 programmes will reduce the overall injury rate compared to 
control (no or sham intervention) in football. 
METHODS 
Literature search 
We will conduct a systematic review following the PRISMA statement13 and prospectively register 
the review in PROSPERO. We will carry out a systematic search in the following bibliographic 
databases: Medline via Pubmed, Embase via OVID, CINAHL via Ebsco, Web of Science, SportDiscus 
and Cochrane Central Register of Controlled Trials, from 2004 to the 14th of March 2016, as the 
FIFA 11 prevention programmes were initiated and implemented from 2004-2005.9;14 A hand-
search of the reference lists of relevant articles will also be conducted for other potential relevant 
references and FIFA - Medical Assessment and Research Centre (F-MARC) will be contacted to 
verify if any important FIFA 11 or FIFA 11+ studies/publications do not appear from the search. No 
restrictions on language will be included in the search.  
 
The following search strategy was tested to be the most efficient across databases, and will be 
applied in all the databases mentioned above:  
 
(fifa OR f-marc OR fmarc OR prevention program* OR warm-up program* OR warmup program* 
OR the11)  
 
AND  
 
(football OR foot ball OR soccer)  
 
Study selection 
For estimating the effect of the FIFA 11 programmes on injury rates we will only include 
randomised or cluster randomised controlled trials comparing the FIFA 11 prevention programmes 
with a control (no or sham intervention) among football players. To be included studies have to 
fulfil the following criteria: (1) Full-text paper published in peer-reviewed journal shall be 
available; (2) Contain original data from a randomised or a cluster randomised trial; (3) Evaluate 
the preventive effect of FIFA 11 or the FIFA 11+ programme; (4) Include football players only (5) 
Investigate football injury as the outcome.  
 
Compliance to the FIFA 11 or the FIFA 11+ programmes will be investigated from the included 
randomised and/or cluster randomised studies. 
In the search of possible adverse events reported in relation to actually performing the FIFA 11 
programmes (adverse events experienced while performing the programmes), we will also include 
all other original studies or reports including practical execution of the FIFA 11 programmes. This 
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in order to look at possible adverse events related to the FIFA 11 programmes in football players. 
Possible adverse events will be reported as a secondary outcome in this systematic review.  
Possible relevant studies, identified by titles and abstracts, from the search are downloaded into 
Reference Manager and duplicates are removed. Two authors (KT and KK) will independently 
perform the selection of studies based on the full references given by the bibliographic databases. 
This will be followed by full text evaluation of the selected studies from the first selection step. 
Disagreement between the two reviewers will be solved by consensus involving a third reviewer 
(EMB). 
  
Data extraction and risk of bias assessment 
Two reviewers (EE and MBC) will independently extract data using a specifically designed 
standardized data extracting form (Appendix 1) and compare the extracted data afterwards for 
consistency. All inconsistencies between the two forms will be resolved by discussion between the 
two data extractors. Any disagreement between the data extractors after the initial discussion 
related to inconsistencies between the two individual data extractions will be solved involving a 
third person (EMB). General study information, participants and intervention characteristics, 
compliance, adverse events, withdrawals and outcome measures will be extracted (Appendix 1). If 
data is not available from tables or the result section, the authors of the study in question will be 
contacted. Whenever possible, results from the intention-to-treat population will be used. 
 
Included randomised and cluster-randomised studies will be assessed for risk of bias by two 
independent raters (EE and MBC) using the Cochrane Collaboration’s tool for assessing risk of bias 
in randomised trials.15 Each trial will be evaluated across seven domains of bias, including one or 
more items that are appraised in two parts. Firstly, the relevant trials’ characteristics related to 
the item will be summarized. Secondly, each bias domain is judged as high or low risk of bias, 
according to their possible effect on the results of the trial. When the possible effect is unknown 
or insufficient detail is reported, the item is judged as unclear. All the above concerning risk of bias 
will follow the description in the Cochrane Handbook for Systematic Review of Interventions, 
version 5.1 (Part 2: 8.5.1).15 When we assess risk of bias in cluster-randomised trials, particular 
types of bias are included in the “other bias” domain, according to how to assess risk of bias in 
cluster-randomised trials recommended in Cochrane Handbook for Systematic Review of 
Interventions, version 5.1 (Part 3: 16.3.2).15 Any disagreements between ratings will be resolved 
by discussion between the raters. Consultation with a third party (EMB) will be used if 
disagreements still appear after this discussion. An assessment of the methodological quality will 
not be performed, as no evidence for such appraisals and judgements exists and therefore can be 
misleading when interpreting the results.15 The use of quality scales and summary scores is 
considered problematic due to considerable variations between items and dimensions covered in 
these scales, with little evidence relating to the internal validity of these assessments.16 
 
The risk of bias assessment includes the following seven domains: Random sequence generation 
(selection bias), Allocation concealment (selection bias), blinding of participants and researchers 
(performance bias), blinding of outcome assessment (detection bias), incomplete outcome data 
(attrition bias), selective reporting (reporting bias), and other bias (including specific bias for 
cluster-designed studies). High risk of bias is to be expected from the domains concerning blinding 
of participants and researchers (performance bias), and blinding of outcome assessment 
(detection bias). This, because in prevention studies using active exercise programmes, such as the 
FIFA 11 programme, it is not possible to blind the participants from the intervention, or the 
outcome assessment as the reporting of injuries are self-reported by definition in such studies. 
Therefore, risk of bias assessment was followed as recommended by Cochrane Handbook for 
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Systematic Review of Interventions, version 5.1 (Part 2: 8.5.1)15 and (Part 3: 16.3.2)15 but not 
considered for sensitivity analyses in the final evaluation of the primary or the secondary outcome 
(The risk of bias assessment form can be seen in Appendix 2) 
 
Primary outcome 
Overall injury incidence defined as the number of injuries per 1000 hours of football exposure. 
This includes all injuries (overuse and traumatic) sustained during the study period in both training 
and match.  
 
Secondary Outcomes 
Overall injury incidence defined as the number of injuries per 1000 hours of football exposure. 
This includes all injuries (overuse and traumatic) sustained during the study period in both training 
and match. 
 
Lower limb injury incidence defined as the number of lower limb injuries per 1000 hours of 
football exposure. This includes all lower limb injuries (overuse and traumatic) sustained during 
the study period in both training and match. 
  
Region specific lower limb injury incidence for hamstring, knee and ankle, respectively, defined as 
the number of these injuries per 1000 hours of football exposure. This includes all injuries 
(overuse and traumatic) sustained during the study period for each of these regional injuries in 
both training and match. 
 
Compliance to the intervention will be estimated as the number of FIFA prevention programme 
sessions performed during the intervention period divided by the length of the intervention period 
in months. The mean compliance for each study included in the primary analysis will be estimated 
from data available in the included trials. For the same trials the compliance for each individual 
team will be estimated from similar data, at team level, obtained directly from the authors of the 
original trials. Accordingly, data at team level will be obtained on: Total number of injuries; Total 
exposure time (hours); Number of FIFA prevention programme sessions performed, and the 
duration of the FIFA prevention programme exercise period (months). The first author of this 
systematic review (KT) will contact corresponding authors of all randomised and cluster 
randomised studies included in the primary analysis concerning these compliance/injury data, and 
ask them to provide this information in a pre-specified form on compliance and injury rates at 
team level (Appendix 3). 
 
Reports on the number and type(s) of adverse effects related to the actual execution of the FIFA 
programmes (experienced while performing the prevention exercises) in relation to the number of 
players in the studies, will be reported. 
 
Data synthesis and analyses 
Primary analysis 
The incidence rate ratio (IRR) and 95% confidence intervals will be estimated as relative effect size 
using the extracted data on the overall injury incidence (typically reported as the total number of 
injuries per 1000 hours), as this is predefined as the primary outcome. If the injury incidence is not 
available in the published article the first author (KT) of the systematic review will send an email to 
the author(s) and ask for the data. If exposure is not available, we will use the number of injuries 
instead. 
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If cluster randomised trials provide a cluster-adjusted estimate, we will use it. If trials don’t report 
the cluster-adjusted estimates we will use the intra-cluster correlations coefficient (ICC) from their 
own trial (if reported) or use the intra-cluster correlations coefficient (ICC) from similar trials to 
adjust for a potential cluster effect by calculating the inflation factor (IF). The equation for cluster 
adjustment is IF= 1+(n-1)ρ, where ρ is the intracluster correlation coefficient, n the average cluster 
size and IF the inflation factor.15;17 Effective sample size is calculated by dividing the number of 
injuries and amount of exposure hours with the IF as described in the Cochrane Handbook for 
Systematic Review of Interventions, version 5.1 (Part 3: 16.3.4).15  
 
Review Manager version 5.3 (Copenhagen: The Nordic Cochrane Centre, The Cochrane 
Collaboration) will be used when calculating the pooled IRR. A forest plot will be used to allow for 
easy visual comparisons between studies. The level of statistical heterogeneity for pooled data will 
be established using the χ2 and I2 statistics. The χ2 and I2 statistics describe heterogeneity or 
homogeneity of the comparisons with p<0.05 indicating a significant heterogeneity.18 The Mantel-
Haenszel19;20 random effects method will be selected as default option.  
 
Secondary exploratory analyses 
IRR and 95% confidence intervals will be estimated as relative effect size using the extracted data 
on the incidence of all lower limb injuries, and for overall injuries in the following subgroups: 
gender (male and female), and mean age groups (youth (<19 years), Senior (19-30 years), Old 
girls/boys (31-39 years), Veteran (>39 years)), and type of programme (FIFA 11 or FIFA 11+). If 
mean age is not provided, then median age will be used for the same age categories. The 
association between compliance to the programme and the injury incidence will be performed in 
two ways: one on study level and one on team level. The association between compliance and 
preventive effect will be analysed through estimating the association between the injury incidence 
from the individual studies and the average compliance in the individual studies using meta-
regression analysis in Stata. To counteract a potential heterogeneous compliance between the 
teams in the individual studies, we will also estimate the association between the injury incidence 
and the compliance at team level using Poisson regression as previous done by Soligard et al 
(2010).21 This analysis will only include teams randomised to the prevention intervention (meaning 
one of the FIFA programmes).  
 
Post-hoc analysis 
Any other analysis deviating from the planned analyses will be considered post-hoc analysis. 
 
Implementation of statistical analyses plan   
This statistical analyses plan (SAP) will be used as a work description for the person performing the 
statistical analyses (MSR). All analyses will be performed by the same person (MSR), and none of 
the other investigators involved in this trial will perform any of the statistical analyses. The 
implementation of the SAP will be as follows: 1. A “data extraction form” will be outlined in 
collaboration between the principal investigator (KT) and senior author (MSR). The authors 
involved in the data extraction (EE) and (MBC) will code each intervention arm into ‘group A’ and 
‘group B’, for the statistical analyses. Data will be delivered by EE and MBC to MSR according to 
the “data extraction form”. Primary and secondary analyses concerning the comparison of the two 
groups (intervention versus no or sham intervention) will be carried out using the same approach. 
Results will be presented by MSR to the writing committee of the systematic review (identical to 
all the other authors of this systematic review). The writing committee will then view the results of  
the analyses and thereby find out which of the pre-planned conclusions that should to be used in 
the first line of the conclusion in the manuscript (defined below). Any queries or disagreements 
concerning the conclusion in relation to the primary hypothesis will be discussed in the writing 
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committee and among all co-authors, and any final deviations from this will be specified in the 
discussion and conclusion section of the final manuscript and research publication. The primary 
hypothesis and the related pre-planned conclusion possibilities are outlined in the following 
section. 
 
 
Primary hypothesis and pre-planned conclusion 
As our primary hypothesis is that the FIFA 11 programmes will reduce the overall injury rate 
compared to control (no or sham intervention) in football, we will test this hypothesis. One of 
three possible scenarios can be expected.  
 
1) If the 95% confidence intervals (95%CI) of the incidence rate ratio (IRR) are below 1, and 
does not include 1, we will in the first line of the conclusion in both manuscript and 
abstract conclude that:   
 
An injury preventive effect of the FIFA 11 programmes compared to control (no or sham 
intervention) could be documented in football. 
2) If the 95% confidence intervals (95%CI) of the incidence rate ratio (IRR) include 1, we will in 
the first line of the conclusion in both manuscript and abstract conclude that:  
No injury preventive effect of the FIFA 11 programmes compared to control (no or sham 
intervention) could be documented in football. 
3) If the 95% confidence intervals (95%CI) of the incidence rate ratio (IRR) are above 1, and 
does not include 1, we will in the first line of the conclusion in both manuscript and 
abstract conclude that:  
In contrast to our hypothesis, that the FIFA 11 programmes compared to control (no or sham 
intervention) will reduce injuries, the data shows that the FIFA 11 programmes are associated with 
an increased number of injuries compared to control (no or sham intervention) in football. 
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APPENDIX 1: 
DATA EXTRACTION FORM 
 
Reviewer:       Date:        Study number:        
 
 
GENERAL STUDY INFORMATION 
First author (e.g. Smith F):        
Correspondence to:           Detail not provided 
Title:       
Journal:           
Year of publication:      Vol.:      Num.:      Pages:        
Country:         Language:       
Sources of support:       
 
STUDY DESIGN 
 Randomised Controlled Trial  
 Cluster Randomised Controlled Trial  
 Not Randomised Trial (jump to non-randomised section) 
 
Setting: Unicenter Multicenter ( National / International)  Detail not provided 
 
Recruitment period (months):                                 Detail not provided 
 
STUDY POPULATION AND PARTICIPANTS 
Study population description:       
Inclusion criteria:       
Exclusion criteria:       
Flow of participants 
 Groups 
Intervention / Control Reasons / Details 
Invited to participate             
Declined to participate             
Excluded             
Randomized              
Dropouts             
Completed             
Analysed             
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Baseline characteristics 
 
Variables 
Total:  
(n=     ) 
Intervention 
(n=     ) 
Control  
(n=     ) Between group difference (statistically significant) 
Age (     )                    Yes      No 
Gender (M/F)                    Yes      No 
Weight (     )                    Yes      No 
Height (     )                    Yes      No 
BMI (     )                    Yes      No 
                         Yes      No 
 
INTERVENTION 
Intervention general description and objectives:       
Duration (weeks/months):        
Intervention characteristics 
Group Programme Supervision Frequency Session duration 
Intervention 
 The 11   
     
 The 11+                        
                  
Control                         
 
DATA COLLECTION 
Follow up (months):       
Definition of injury:     Yes  No 
If yes: 
Time loss  
Medical attention  
Other (describe): 
Data collection procedures 
Variables Responsible (who collected data) 
Method 
(scale, instrument, etc.) 
Frequency of 
collection Details 
Exposure time                         
Number of injuries                         
Characteristic of 
injuries                         
Compliance with 
the intervention                         
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RESULTS 
Drop-outs 
Group Num. (%) Description/Reasons 
Total             
   Intervention             
   Control               
Exposure (h) 
 Total exposure Intervention  Control  
Total                    
   Training                    
   Match                      
Results on injury incidence including 95% confidence interval 
 Intervention  
(n=     ) Control (n=     ) 
Overall injury incidence             
  Lower limb injury incidence             
   Hamstrings injury             
   Knee injury incidence             
   Ankle injury incidence              
Results on number of injuries 
 Total 
(n=     ) 
Intervention  
(n=     ) 
Control  
(n=     ) 
Number of overall injuries                   
  Number of lower limb injuries                   
   Number of hamstrings injuries                   
   Number of knee injuries                   
   Number of ankle injuries                    
Compliance 
Pre-defined compliance in the study:        Yes                 No  
If yes, describe:       
 
Main descriptions of interest Intervention Group 
Number of times that the prevention programme was performed during the 
intervention period        
Proportion of preventive intervention sessions performed in relation to preventive 
intervention sessions initially planned (%) 
      
Proportion of training/match sessions in which the preventive programme was 
performed in relation to the total number of training/match sessions during the 
intervention (%) 
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ADVERSE EVENTS  
Adverse events reported in relation to performing (during) the prevention programme 
Registering adverse events          Yes                 No 
Results Total:       Intervention group:       
Descriptions (type of 
adverse events, etc.):         
 
 
CONCLUSIONS 
Conclusions 
Primary outcome:       
 
 
 
COMMENTS 
(Add general comments if relevant) 
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METHODOLOGICAL DETAILS 
 
Methodological details  
 Description / details 
Eligibility criteria 
specified 
 Yes      No  
      
Power calculation  Yes     No    Not reported 
      
Estimated ICC for 
power calculation  
 Yes     No        
(if yes, provide ICC value in description / details) 
      
Method of 
randomization 
 Adequate / computer generated 
 Inadequate 
 Not reported 
      
Allocation 
concealment 
 Adequate   
 Doubtful 
 Inadequate 
 Not reported 
      
Blinding 
Participants:  Yes    No 
Therapist/s:   Yes    No 
Outcome assessor/s:  Yes  No  Not reported 
      
Follow up 
Same duration for all players?  
  Yes (Duration:       months) 
  No (Mean duration:       months) 
 Not reported 
      
Handling of 
withdrawals 
description  
 Yes      No     Not reported 
      
Intent to Treat  Yes      No     Not reported 
      
Pre-published study 
protocol 
 Yes      No 
      
 
                                                                                                                              Version 1.1, 29th February, 2016                
 16 
 
Additional data to be extracted for Cluster Randomised Controlled 
Trials Description / details 
Taking clustering 
effects into account 
during analyses 
 Yes     No     Not reported 
      
Reported ICC related 
to clustering effects  
 Yes     No     
(if yes, provide ICC value in description / details) 
      
Comparable clusters 
at baseline 
 Yes     No     Not reported 
      
Recruitment after 
randomisation 
 Yes     No     Not reported 
      
Number of clusters 
in control and 
intervention group 
 Yes     No     Not reported 
Intervention   Control 
 
                          
Average cluster size  Yes     No     Not reported 
Intervention   Control 
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SECTION ONLY FOR NOT RANDOMISED TRIALS 
 
 
STUDY POPULATION AND PARTICIPANTS 
Study population description:       
Baseline characteristics 
 
Variables Total:  
(n=     ) 
Intervention 
(n=     ) 
Control (n=   
  ) 
Between group difference 
(statistically significant) 
Age (     )                    Yes      No 
Gender (M/F)                    Yes      No 
Weight (     )                    Yes      No 
Height (     )                    Yes      No 
BMI (     )                    Yes      No 
                         Yes      No 
 
INTERVENTION 
Intervention general description and objectives:       
Duration (weeks/months):        
Intervention characteristics 
Group Programme Supervision Frequency Session duration 
Intervention 
 The 11   
     
 The 11+                        
                  
Control                         
 
ADVERSE EVENTS  
Adverse events reported in relation to performing (during) the prevention programme 
Registering adverse events          Yes                 No 
Results Total:       Intervention group:       
Others descriptions:        
 
 
 
 
COMMENTS 
(Add general comments of the article if relevant) 
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APPENDIX 2:  
 
 
 
 
RISK OF BIAS ASSESSMENT FORM 
 
 
Reviewer:        
 
 
 
First author (year):       (     ) Assessment data:       Study number:       
Bias domain 
Author’s judgment 
(low, unclear, high) Support for judgment 
Random sequence 
generation (selection bias)             
Allocation concealment 
(selection bias)             
Blinding of participants and 
researchers (performance 
bias) 
            
Blinding of outcome 
assessment (detection bias)             
Incomplete outcome data 
(attrition bias)             
Selective reporting (reporting 
bias)             
Other bias             
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APPENDIX 3: 
 
REQUESTED INFORMATION FORM FROM CORRESPONDING AUTHORS 
OF ALL INCLUDED RANDOMISED OR CLUSTER RANDOMISED TRIALS 
(COMPLIANCE AND INJURY RATES AT TEAM LEVEL) 
 
Team_ID Total number of  injuries (overall) 
Total exposure time  
(hours) 
Number of FIFA 
11/11+ sessions 
performed 
 
Duration of the FIFA 
11/11+ exercise period 
(months) 
 
          
          
          
          
          
          
          
          
          
          
          
          
          
          
     
